TFOS DEWS II report executive summary

JP Craig, JD Nelson, DT Azar, C Belmonte, AJ Bron… - The ocular …, 2017 - Elsevier
This article presents an Executive Summary of the conclusions and recommendations of the
10-chapter TFOS DEWS II report. The entire TFOS DEWS II report was published in the July …

Tfos dews ii iatrogenic report

JAP Gomes, DT Azar, C Baudouin, N Efron… - The ocular …, 2017 - Elsevier
Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of
patients looking for eye care or cosmetic procedures involving the eyes, together with a …

Dry eye disease: prevalence, assessment, and management

PA Rouen, ML White - Home healthcare now, 2018 - journals.lww.com
Dry eye disease is a chronic condition of the corneal surface marked by persistent symptoms
of irritation or burning that can cause inflammatory damage to the cornea and conjunctiva if …

[HTML][HTML] Intense pulsed light treatment in meibomian gland dysfunction: a concise review

B Tashbayev, M Yazdani, R Arita, F Fineide… - The ocular surface, 2020 - Elsevier
Purpose To review the published literature related to application of intense pulsed light (IPL)
for treating meibomian gland dysfunction (MGD). Methods The literature search included the …

Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study

R Toyos, NR Desai, M Toyos, SJ Dell - PLoS One, 2022 - journals.plos.org
Purpose To compare the safety and efficacy of intense pulsed light (IPL) followed by
meibomian gland expression (MGX), against monotherapy of MGX. Methods Patients with …

Categorization of marketed artificial tear formulations based on their ingredients: a rational approach for their use

A Kathuria, K Shamloo, V Jhanji, A Sharma - Journal of Clinical Medicine, 2021 - mdpi.com
Dry eye disease is a common ocular condition affecting millions of people worldwide.
Artificial tears are the first line therapy for the management of dry eye disease. Artificial tear …

Recent developments about the pathogenesis of dry eye disease: Based on immune inflammatory mechanisms

L Yu, C Yu, H Dong, Y Mu, R Zhang, Q Zhang… - Frontiers in …, 2021 - frontiersin.org
Dry eye disease is a common and frequently occurring ophthalmology with complex and
diverse causes, and its incidence is on the upward trend. The pathogenesis of DED is still …

[HTML][HTML] Ocular immune-related adverse events associated with immune checkpoint inhibitors in lung cancer

L Zhou, X Wei - Frontiers in Immunology, 2021 - frontiersin.org
Immune checkpoint inhibitors (ICIs) are novel immunotherapy-based drugs that have
become increasingly popular in the treatment of lung cancer. Researchers have recognized …

[HTML][HTML] Physicochemical properties of hyaluronic acid–based lubricant eye drops

P Aragona, PA Simmons, H Wang… - … Vision Science & …, 2019 - arvojournals.org
Methods: The average molecular weight (MW) and polydispersion index (PDI) of HA in 18
commercially available artificial tears were determined by light scattering/high-performance …

[HTML][HTML] The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a …

X Yan, J Hong, X Jin, W Chen, B Rong, Y Feng… - Eye & contact …, 2021 - journals.lww.com
Objectives: To compare the efficacy of intense pulsed light (IPL) combined with Meibomian
gland expression (MGX), and instant warm compresses combined with MGX, for treatment of …